Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New software aims to tame blood sugar chaos in hospitals

NCT ID NCT05447806

First seen May 15, 2026 · Last updated Jun 22, 2026 · Updated 9 times

Summary

This study tests a computer program called GlucAlert-CDS that alerts doctors when hospitalized patients have dangerously high or low blood sugar. The tool suggests care recommendations to improve glucose control. Researchers will compare periods when the tool is active versus inactive, involving over 15,000 adult patients across multiple hospitals, to see if it reduces hospital stays and complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERGLYCEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Penn State Health St. Joseph Medical Center

    RECRUITING

    Reading, Pennsylvania, 19605, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Penn State Hershey Medical Center

    RECRUITING

    Hershey, Pennsylvania, 17033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Electronic medical record clinical decision support tool (GlucAlert-CDS)

What this could lead to

If successful, this tool could help hospitals better manage blood sugar levels in patients, potentially reducing complications and shortening hospital stays.

What could go wrong

This is a large observational-style study testing a software tool, not a new drug. The tool may not significantly improve outcomes, and results may vary across different hospital settings.

Conditions

The condition(s) this trial relates to.

diabetes mellitus hyperglycemia hypoglycemia prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.